Inflammation is associated with macrophage activation, and this process has been shown to occur during atherogenesis. Macrophages (J774A.1) that were activated with either lipopolysaccharide (LPS), zymosan, or phorbol ester demonstrated a 30-35% increased uptake and degradation of low density lipoprotein (LDL) in comparison with nonactivated cells. This phenomenon was also shown for LDL cellular binding, and it resulted in macrophage cholesterol accumulation, as evidenced by cholesterol mass determination and flow cell cytometric analysis. Enhanced uptake of LDL was also obtained with two other types of macrophages: mouse peritoneal macrophages and human monocyte-derived macrophages. In LPSstimulated macrophages, high density lipoprotein-mediated cholesterol efflux was not different from that shown in nonstimulated cells. Cellular cholesterol synthesis, however, was increased by 25% in the activated macrophages. Macrophage activation, measured as cellular procoagulant activity, was higher in cholesterol-loaded than in nonloaded cells. On stimulation of cholesterol-loaded macrophages, cellular uptake and degradation of LDL were increased by 3.3-fold in comparison with nonactivated cholesterolloaded cells. Human monocyte-derived macrophages from hypercholesterolemic patients were found to contain 52% more cholesterol mass than macrophages derived from normal healthy donors. These cells demonstrated increased activation (twofold) in response to LPS stimulation and also showed 25% enhanced cellular degradation of LDL. We conclude that activation of macrophages during atherogenesis can lead to foam cell formation, and this mechanism is probably operative in hypercholesterolemic 
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Inflammation is associated with macrophage activation, and this process has been shown to occur during atherogenesis. Macrophages (J774A.1) that were activated with either lipopolysaccharide (LPS), zymosan, or phorbol ester demonstrated a 30-35% increased uptake and degradation of low density lipoprotein (LDL) in comparison with nonactivated cells. This phenomenon was also shown for LDL cellular binding, and it resulted in macrophage cholesterol accumulation, as evidenced by cholesterol mass determination and flow cell cytometric analysis. Enhanced uptake of LDL was also obtained with two other types of macrophages: mouse peritoneal macrophages and human monocyte-derived macrophages. In LPSstimulated macrophages, high density lipoprotein-mediated cholesterol efflux was not different from that shown in nonstimulated cells. Cellular cholesterol synthesis, however, was increased by 25% in the activated macrophages. Macrophage activation, measured as cellular procoagulant activity, was higher in cholesterol-loaded than in nonloaded cells. On stimulation of cholesterol-loaded macrophages, cellular uptake and degradation of LDL were increased by 3.3-fold in comparison with nonactivated cholesterolloaded cells. Human monocyte-derived macrophages from hypercholesterolemic patients were found to contain 52% more cholesterol mass than macrophages derived from normal healthy donors. These cells demonstrated increased activation (twofold) in response to LPS stimulation and also showed 25% enhanced cellular degradation of LDL. We conclude that activation of macrophages during atherogenesis can lead to foam cell formation, and this mechanism is probably operative in hypercholesterolemic patients. (Arteriosclerosis and Thrombosis 1992;12:745-753) KEYWORDS • macrophage activation • hypercholesterolemia low density lipoproteins • cholesterol • lipopolysaccharide I nflammation processes and atherogenesis are both associated with macrophage activation. 12 Macrophages play an important role in the immune and the inflammatory body responses, and lipoprotein-antibody immune complexes have been shown to form foam cells. 34 Monocyte-derived macrophages can be transformed into foam cells after incubation with modified forms of low density lipoprotein (LDL), including oxidized LDL, but not with native LDL, 5 which is taken up via the cholesterol-regulated LDL receptor. 6 Activated macrophages secrete many products, including polypeptides, enzymes, growth factors, free radicals, and coagulation factors. 7 -8 Thus, under conditions of macrophage activation, these secreted substances can possibly affect the atherogenic process. Lipopolysaccharide (LPS) is a glycolipid that is present in the outer membrane of all Gram-negative bacteria, and LPS has been shown to be a potent activator of various cells, including macro- patients with familial hypercholesterolemia (FH, with plasma cholesterol >300 mg/dl). Twenty milliliters of blood (anticoagulated with 100 units heparin/ml) was layered over 15 ml Ficoll-Paque and centrifuged at 500g for 30 minutes at 23°C. The mixed mononuclear cell band was removed by aspiration, and cells were washed twice in RPMI-1640 culture medium containing 100 units/ml penicillin, 100 fig/ml streptomycin, and 2 mM glutamine. The cells were plated at 10 6 mononuclear cells per 16-mm dish (Primaria, Falcon Labware, Becton Dickinson, Oxnard, Calif.) in the same medium in the presence of 20% fetal calf serum. After 2 hours of incubation at 37°C in 5% CO 2 /95% air, nonadherent cells were removed (by three washes with serum-free medium), were placed in a similar fresh medium in the presence of 20% autologous serum, and were fed twice weekly with the same medium. Macrophages were used 7-10 days after plating and contained approximately 5 x 10 5 cells per dish.
Mouse peritoneal macrophages were harvested from the peritoneal fluid of BALB/c mice (weight, 15-25 g) 4 days after intraperitoneal injection into each mouse of 3 ml 24 g/1 thioglycolate in saline. The cells (20xl0 6 per mouse) were pooled, treated with 3 ml 8.3 g/1 NaCl (pH 7.4), and incubated for 5 minutes at 37°C to remove red LPS Concentration(/ug/ml) blood cell contamination. The cells were washed and centrifuged three times with phosphate-buffered saline at 400g for 10 minutes and then resuspended to 10 9 /l in DMEM containing 10% horse serum (heat inactivated at 56°C for 30 minutes). The cell suspension was dispensed into 16-mm plastic dishes and incubated for 2 hours. The dishes were washed once with DMEM to remove nonadherent cells, and the monolayer was then incubated with DMEM under similar conditions for 18 hours before the experiment.
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Lipoproteins LDL was prepared from human plasma (in 4 mM EDTA) drawn from fasted normolipidemic volunteers. LDL (d= 1.019-1.063 g/ml) was prepared by discontinuous density gradient ultracentrifugation in a Beckman VT 50.1 vertical rotor (Beckman Instruments, Fullerton, Calif.) as described previously. 12 The lipoprotein was washed at d= 1.063 g/ml and dialyzed against 150 mM NaCl, 1 mM EDTA, pH 7.4. LDL was then sterilized by filtration and was used within 2 weeks.
LDL was iodinated by the method of McFarlane as modified for lipoproteins. 13 repeated additions of acetic anhydride to 10 mg/ml LDL diluted 1:1 (vol/vol) with saturated ammonium acetate at 4°C. Acetic anhydride was added at a 40-fold molar excess with regard to total lysines in LDL, and the modification was confirmed by electrophoresis on cellulose acetate at pH 8.6 in barbital buffer.
Lipoprotein Metabolism by Macrophages
LDL cellular degradation was measured after incubation of 125 I-LDL (150-250 cpm/ng) with the cells for 5 hours at 37°C. The hydrolysis of LDL protein was assayed in the incubation medium by measurement of trichloroacetic acid-soluble, noniodide radioactivity.
14 Cell-free LDL degradation was minimal and was subtracted from total degradation. The cell layer was washed three times with phosphate-buffered saline and incubated with 0.1N NaOH for 1 hour at room temperature for measurement of cellular protein content. 15 Cholesterol esterification rate was measured as the incorporation of [ 3 H]oleate as previously described. 16 The cells were incubated in the presence of the lipoproteins for 18 hours at 37°C. During the last 2 hours of incubation, [ 3 H]oleate in complex with albumin (2.7 mM, 83 mmol oleate/mg albumin, 10 juCi/ml) was added to the medium. At the end of the incubation, cellular lipids were extracted with hexane/isopropanol (3:2, vol/vol), and the cholesteryl ester was separated by thin-layer chromatography (TLC) using hexane/ether/acetic acid (130:30:1.5, vol/vol/vol), scraped into vials containing 15 ml scintillation fluid, and counted in a beta scintillation counter.
Cellular contents of unesterified cholesterol, cholesteryl ester, and total cholesterol mass were determined using the ferric chloride assay. 17 Cellular binding of LDL was analyzed at 4°C after 4 hours of LDL incubation with the cells. 18 Cellular cholesterol efflux was determined in J774A.1 macrophages that were loaded with cholesterol by 18 hours of incubation with acetylated LDL (100 /xg acetylated LDL protein/ml) and [ 3 H]cholesterol (Amersham Corp., Arlington Heights, 111.; 0.5 /xCi/ml, 55 Ci/mmol, added in ethanol) for the same time of incubation. At the end of the incubation, the cells were washed three times in serumfree medium and further incubated with high density lipoprotein subfraction 3 (HDL3) (25 /u.g protein/ml) for 5 hours at 37°C. Radioactivity in the cells and the media (after centrifugation to remove detached cells) was measured. Macrophage cholesterol synthesis was measured in cells after 2 hours of incubation with 1,2-sodium [
14 C]acetate (1.25 mM, 10 /iCi/ml). At the end of the incubation, the cells were washed with phosphate-buffered saline, and the radioactivity incorpo- 50 100
LDL Concentration(/i.g/ml) rated into the cholesterol moiety was determined by TLC.
Procoagulant Activity of Macrophages
The procoagulant activity (PCA) was measured using the prothrombin time assay. The supernatant (50 fi\ of 5 x 10 5 sonicated cells) that was obtained after centrifugation (l,OOQg for 10 minutes) was mixed with 50 fi\ standard human plasma and incubated for 2 minutes at 37°C. Then 50 /xl 0.025 M CaCl 2 solution was added, and the time required for clot formation was determined. 19 
Experimental Procedure
Macrophages were preincubated with LPS (200 fig/ ml) for 18 hours at 37°C followed by a wash with serum-free medium before the addition of LDL (25-100 fig protein/ml) for analysis of cellular degradation of the lipoprotein, LDL binding, LDL-mediated stimulation of cellular cholesterol esterification rate, and macrophage cholesterol mass. Flow cell cytometry sorting (FACS) was used for macrophage lipid content analysis.
Nile red was incubated for 5 minutes with the cells, and the fluorescence intensity was measured using an excitation wavelength of 480 nm and an emission wavelength of 610 nm.
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Statistics
The nonpaired Student's t test was used. Results are given as mean±SD.
Results
Low Density Lipoprotein Uptake by Activated Macrophages
Macrophage activation with LPS, phorbol ester, or zymosan resulted in a 25-30% increment in cellular degradation of LDL Concentration(/zg/ml) the formation of thiobarbituric acid-reactive substances and it migrated on cellulose acetate like native LDL (data not shown). Furthermore, the addition of 25 fiM butylated hydroxytoluene to the cells for the 5-hour incubation with Figure 3A) . Similarly, macrophage cholesterol mass was increased by as much as 1.4-fold in the presence of 300 fig/ml LPS ( Figure 3B ). FACS analysis further demonstrated that the activation process increased the lipid content of the cells. LPS activation of the cells followed by cell incubation with LDL demonstrated a fluorescence intensity increase of 37% in comparison with the nonstimulated cells that were incubated without LDL (Figure 4 ).
Low Density Lipoprotein Concentration Study and Involvement of the Low Density Lipoprotein Receptor
The LDL concentration study revealed that at all concentrations, LPS increased cellular LDL degradation ( Figure 5 Figure  6A ). Linearization of these data suggests that the major 125 J774A.1 macrophages were loaded with cholesterol by incubation with 200 jig/ml acetylated low density lipoprotein (LDL) for 18 hours at 37°C. Cellular cholesterol content increased from 25±5 to 65±9 /ig/mg cell protein (n=3). Cholesterol-loaded cells and nonloaded cells were activated with 200 jig/ml lipopolysaccharide for 18 hours at 37°C followed by medium removal and a further incubation in fresh medium containing increasing concentrations of 125 I-LDL for 5 hours at 37°C for degradation analysis.
FIGURE 9. Bar graph showing effect of macrophageconditioned medium (MCM) from activated cells on low density lipoprotein (LDL) degradation. J774A.1 cells were preincubated with lipopolysaccharide (LPS; 300 fig/ml) or with MCM that was obtained from cells after 18 hours of incubation with 300 ng/ml LPS. Cells were then washed in serum-free medium and incubated with
I-LDL (25 ftg protein/ml) for 5 hours for LDL degradation analysis. *p<0.01 vs. control (n=3).
effect of LPS on the cells was to increase the "apparent Bmax" by about fourfold ( Figure 6B ). To elucidate the nature of the macrophage receptor for LDL on activated cells, competition experiments were carried out using 10 /xg protein/ml of 125 I-LDL and increasing concentrations of unlabeled LDL or acetylated LDL. Figure 7 demonstrates that in LPS-stimulated (200 Atg/ml) cells, 125 I-LDL degradation was substantially inhibited by excess unlabeled LDL but not acetylated LDL ( Figure 7B) , as was also shown for nonstimulated cells ( Figure 7A ). Similar to the effect of LPS on J774A.1 macrophages, enhanced cellular LDL degradation was also observed when mouse peritoneal macrophages or HMDMs were used. With these two cell types, LDL degradation was increased after pretreatment with LPS by as much as 86% and 59%, respectively (Figure 8 ).
Cellular Cholesterol Efflux and Synthesis in Activated Macrophages
Cellular cholesterol content is determined not only by LDL-mediated cholesterol influx but also by HDLmediated cholesterol efflux, as well as by the cellular cholesterol synthesis. LPS stimulation of macrophages did not affect HDL-mediated efflux of cholesterol from cholesterol-loaded J774A.1 cells that were prelabeled with [ 3 H]cholesterol (Table 1) . Cellular cholesterol synthesis, however, was increased in LPS-stimulated cells by 25% in comparison with control cells (Table 1) . J774A.1 macrophages were loaded with acetylated low density lipoprotein for 18 hours at 37°C. Then the cells were washed and incubated with lipopolysaccharide (LPS) (100 jig/ml) for 18 hours at 37°C followed by washing, sonication (twice for 20 seconds), and centrifugation. Procoagulant activity (PCA) in the supernatant was analyzed. *p<0.01, +LPS vs. control (n=3).
Effect of Macrophage-Conditioned Medium
We then compared cellular degradation of LDL by nonactivated macrophages with that produced by cells that were activated with either LPS or conditioned medium from LPS-activated macrophages. When J774A.1 macrophages were preincubated with macrophage-conditioned medium that was obtained from LPS-activated (300 /tg/ml) cells (and thus, contained both macrophage secretory products and LPS), a 43% increment in LDL degradation by macrophages was noted in comparison with a 91% increment in LDL degradation by LPS-activated cells (Figure 9 ).
Low Density Lipoprotein Uptake and Cell Activation in Cholesterol-Loaded Macrophages
J774A.1 macrophages were cholesterol loaded by preincubation with 200 /ug/ml acetylated LDL at 37°C for 18 hours, and this resulted in a cellular cholesterol increment from 25 to 65 /xg/mg cell protein. On activation of cholesterol-loaded macrophages with LPS (200 ju.g/m.1), LDL degradation was increased by as much as threefold in comparison with activated, nonloaded cells, and this effect was LDL-concentration dependent (Table 2). Cellular PCA was measured by incubating cell homogenates with standard plasma and CaCl 2 and monitoring the time required for clot formation. Increased (Table 3) .
Human Monocyte-Derived Macrophages From Hypercholesterolemic Patients
Analysis of the cholesterol content of HMDMs from normolipidemic subjects and patients with FH revealed that HMDMs from hypercholesterolemic subjects contained 47% more cholesteryl ester and 75% more unesterified cholesterol than did cells obtained from normal subjects ( Figure 11A ). Similarly, a 49% increment in cellular cholesterol esterification rate in the cells from FH patients was found ( Figure 11B ). LPS stimulation of FH-derived HMDMs resulted in a twofold increase in macrophage PCA in comparison with that of normolipidemic-derived cells (Table 4) . Similarly, the degradation of I25 I-LDL by HMDMs from LPS-stimulated, FH-derived HMDMs was 25% (/7<0.01) higher than that of LPS-stimulated normolipidemic-derived cells (Table 4) .
Discussion
Activation of cholesterol-loaded macrophages resulted in a substantial increment in the uptake of LDL, which increased cellular cholesterol accumulation. This effect was higher than the stimulatory effect on the cellular uptake of LDL that was demonstrated in activated cells that were not loaded with cholesterol. Macrophage cholesterol accumulation showed a stimulatory effect on the cellular PCA. Similarly in hypercholesterolemic rabbits, increased macrophage plasminogen activator activity was found. 22 The enhanced LDL uptake by activated cholesterol-loaded macrophages was supported by in vivo studies. LPS-stimulated HMDMs from patients with FH, which were shown in this study to be cholesterol enriched, also demonstrated an enhanced PCA and an increased LDL uptake in comparison with LPS-stimulated HMDMs from normolipidemic subjects. These results may suggest that macrophage activation under pathological conditions can be related to foam cell formation and accelerated atherosclerosis. In cholesterol-enriched macrophages, like those found in FH patients, this mechanism was indeed shown to be operative.
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Modified forms of LDL, such as oxidized LDL, were shown to be taken up by the macrophage scavenger receptor.
5
- 6 The scavenger receptor, unlike the LDL receptor, is not regulated by the cellular cholesterol content, and thus, lipoprotein uptake via this receptor can lead to macrophage cholesterol accumulation and foam cell formation.
-
6 Macrophage activation, however, was shown 23 -25 to reduce scavenger receptor activity, so that LDL uptake via this latter receptor could not promote cellular cholesterol accumulation. Furthermore, the involvement of the scavenger receptor in LDL uptake by activated macrophages was ruled out, as shown by the inability of acetylated LDL (the ligand to the scavenger receptor) to compete with 125 I-LDL for its cellular degradation.
Increased LDL uptake by activated macrophages was demonstrated in the present study as well as in other studies, 39 but the present findings contradict a study with murine macrophages elicited by thioglycolate, in which LDL receptor activity was reduced. 26 This may be related to the different stimuli as well as to the fact that macrophage stimulation in that study 26 was obtained by injection of the activators into the mice, whereas the LPS in our study was incubated directly with the cells, and thus, different cellular metabolic properties may have been affected. Increased LDL uptake by activated macrophages could be related (from the Scatchard plot) to increments in both the number of LDL binding sites and the affinity of the lipoprotein to its receptor (increased "apparent B ,^" and reduced "apparent K m "). The Scatchard plot in the present study could also be interpreted as if, after LPS stimulation, two classes of binding sites for LDL appear: one with a high affinity and the other with a low affinity for LDL. The increased receptor activity in LPS-stimulated macrophages was mainly in the low-affinity binding sites, while highaffinity binding was actually almost identical to that shown in the nonstimulated cells. Because cellular cholesterol accumulation in nonactivated cells results in downregulation of the LDL receptor, it should be stated that the increased sensitivity of cholesterol-loaded macrophages to LPS and the increased cellular uptake of LDL may have resulted from factors other than cellular cholesterol content per se, such as prostaglandin formation, second-messenger activation, or other constituents that are secreted from activated cells. 27 Downregulation of the LDL receptor could not be demonstrated under several pathological conditions, such as lipid modifications of LDL 28 " 31 or lipoprotein modification by platelets, 32 in which the LDL uptake by macrophages was significantly increased. Recently, macrophage-secreted oncostatin was also shown to stimulate LDL receptor activity, and this effect was not dependent on the cellular cholesterol content. 33 The stimulatory effect of J774A.1 macrophage activation on LDL uptake was also shown with other stimulators and several types of macrophages and may, therefore, be the link between inflammatory and cardiovascular diseases. 34 Enhanced cellular uptake of LDL is probably related to intracellular changes and not to macrophage-released substance(s) because macrophage-conditioned medium (medium that contained LPS) demonstrated less stimulation of LDL uptake than LPS alone, suggesting an inhibitory effect of macrophagereleased substance(s) on the cellular uptake of LDL.
Another explanation is that because LPS binds to the macrophage membrane and is metabolized by these cells, 35 it might be that in macrophage-conditioned medium less LPS remains in the medium. Unlike native LDL, which is taken up by the LDL receptor, macrophage uptake of modified forms of LDL (acetylated LDL and oxidized LDL, which bind to the macrophage scavenger receptor) was inhibited in LPS-treated cells (in comparison with control cells), and this was related to LPS binding to the macrophage scavenger receptor. Enhanced macrophage activation was associated with increased cellular cholesterol content both in vitro (under conditions of macrophage cholesterol loading) and in vivo (in monocytes-macrophages derived from patients with FH). These results suggest that in the atherosclerotic lesion under conditions of macrophage activation, two processes may occur: 1) induction of macrophage cholesterol accumulation as a result of the enhanced cellular uptake of LDL and 2) further cellular activation by cholesterol-enriched macrophages. These two linked phenomena (cellular activation and cholesterol accumulation) are closely interrelated and may affect each other.
Macrophages are multifunctional cells, and the interrelation between their activation and the cellular uptake of LDL may contribute to acceleration of atherosclerosis. Thus, intervention by various means 37 to inhibit macrophage activation can contribute to a reduction in the atherosclerotic risk via a reduction in LDL uptake by macrophages.
